<<
>>

Christmas Disease

Clinical Manifestations

Christmas disease (hemophilia B), the hereditary functional deficiency of Christmas factor (factor IX), is clinically indistinguishable from classic hemo­philia, and can be differentiated only by laboratory tests.

It is inherited in the same way as an X chromosome-linked disorder and is therefore virtu­ally limited to males. As is true of classic hemo­philia, the disorder varies in severity from family to family in proportion to the degree of the clotting factor deficiency. Christmas disease is heterogene­ous in nature, for in some families the plasma is deficient in Christmas factor, whereas in others the plasma contains one or another of several nonfunc­tional variants of this clotting factor. Therapy for hemorrhagic episodes in Christmas disease is cur­rently best carried out by transfusion of normal plasma, which contains the factor deficient in the patient’s plasma. An alternative therapy, infusion of concentrates of Christmas factor separated from nor­mal plasma, may be needed in some situations, but its use may be complicated by the transmission of viral diseases as well as by other problems.

Geography

Worldwide, Christmas disease is perhaps one-eighth to one-fifth as prevalent as classic hemophilia. Most reported cases have been in individuals of European origin, but in South Africa and in the United States, as reflected by Ohio data, Christmas disease is rela­tively as common in blacks as in whites. Christmas disease of moderate severity is particularly preva­lent among inhabitants of the village of Tenna, in Switzerland, and among Ohio Amish. This disorder is said to be rare in Japan.

<< | >>
Source: Kiple Kenneth F. (Editor). The Cambridge World History of Human Disease. Cambridge University Press,1993. — 1200 p.. 1993

More on the topic Christmas Disease: